Learning from Remsima, A Remicade biosimilar
Posted on16 Feb 2016
TagsA Remicade biosimilar, biocon's biosimilar, Biosimilar, highly similar drugs, Neupogen, Remicade biosimilar, Remsima, Zarxio
Comments0
USFDA staff recently decided that Celltrion and Pfizer’s biosimilar (Remsima) to Johnson & Johnson’s Remicade for rheumatoid arthritis was “highly similar” to... Read More